Abstract
Despite intensive research efforts, by our own team and many others, the molecules responsible for acute neurological damage following subarachnoid hemorrhage (SAH) and contributing to delayed ischemic neurological deficit (DIND) have not yet been elucidated. While there are a number of candidate mechanisms, including nitric oxide (NO) scavenging, endothelin-1, protein kinase C (PKC) activation, and rho kinase activation, to name but a few, that have been investigated using animal models and human trials, we are, it seems, no closer to discovering the true nature of this complex and enigmatic pathology. Efforts in our laboratory have focused on the chemical milieu present in hemorrhagic cerebrospinal fluid (CSF) following SAH and the interaction of the environment with the molecules generated by SAH and subsequent events, including NO scavenging, immune response, and clot breakdown. We have identified and characterized a group of molecules formed by the oxidative degradation of bilirubin (a clot breakdown product) and known as BOXes (bilirubin oxidation products). We present a synopsis of the characterization of BOXes as found in human SAH patients’ CSF and the multiple signaling pathways by which BOXes act. In summary, BOXes are likely to play an essential role in the etiology of acute brain injury following SAH, as well as DIND.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W et al (1994) Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315–2328
Weir B (1995) The pathophysiology of cerebral vasospasm. Br J Neurosurg 9:375–390
Macdonald RL (2001) Pathophysiology and molecular genetics of vasospasm. Acta Neurochir Suppl 77:7–11
Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, Kasuya H, Wellman G, Keller E, Zauner A, Dorsch N, Clark J, Ono S, Kiris T, Leroux P, Zhang JH (2009) Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 31:151–158
Weir B, Grace M, Hansen J, Rothberg C (1978) Time course of vasospasm in man. J Neurosurg 48:173–178
Clark JF, Pyne-Geithman GJ (2005) Vascular smooth muscle function: the physiology and pathology of vasoconstriction. Pathophysiology 12:35–45
Dreier JP, Ebert N, Priller J, Megow D, Lindauer U, Klee R, Reuter U, Imai Y, Einhaupl KM, Victorov I, Dirnagl U (2000) Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 93:658–666
Pyne-Geithman G, Nair S, Caudell D, Clark J (2008) PKC and Rho in vascular smooth muscle: activation by BOXes and SAH CSF. Front Biosci 13:1526–1534
Nair S, Clark JF, Pyne-Geithman GJ (2007) Patterns of protein kinase C and Rho activation during cerebral vasospasm after subarachnoid hemorrhage. Arterioscler Thromb Vasc Biol 27:e43
Lyons MA, Shukla R, Zhang K, Pyne GJ, Sing M, Biehle SJ, Clark JF (2004) Increase of metabolic activity and disruption of normal contractile protein distribution by bilirubin oxidation products in vascular smooth-muscle cells. J Neurosurg 100:505–511
Pyne-Geithman GJ, Morgan CJ, Wagner KR, Dulaney EM, Carrozzella JA, Kanter DS, Zuccarello M, Clark JF (2005) Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26:1070–1077
Petzold GC, Einhaupl KM, Dirnagl U, Dreier JP (2003) Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol 54:591–598
Zuccarello M, Romano A, Passalacqua M, Rapoport RM (1995) Decreased endothelium-dependent relaxation in subarachnoid hemorrhage-induced vasospasm: role of ET-1. Am J Physiol 269:H1009–H1015
Buckell M (1964) Demonstration of substances capable of contracting smooth muscle in haematoma fluid from certain cases of ruptured cerebral aneurysm. J Neurol Neurosurg Psychiatry 27:198–199
Wickman G, Lan C, Vollrath B (2003) Functional roles of the rho/ rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction. Circ Res 92:809–816
Miao FJ, Lee TJ (1989) Effects of bilirubin on cerebral arterial tone in vitro. J Cereb Blood Flow Metab 9:666–674
Kranc KR, Pyne GJ, Tao L, Claridge TDW, Harris DA, Cadoux-Hudson TAD, Turnbull JJ, Schofield CJ, Clark JF (2000) Oxidative degradation of bilirubin produces vasoactive compounds. Eur J Biochem 267:7094–7101
Clark JF, Reilly M, Sharp FR (2002) Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage induced cerebral vasospasm. J Cereb Blood Flow Metab 22:472–478
Morgan CJ, Pyne-Geithman GJ, Jauch EC, Shukla R, Wagner KR, Clark JF, Zuccarello M (2004) Bilirubin as a cerebrospinal fluid marker of sentinel subarachnoid hemorrhage: a preliminary report in pigs. J Neurosurg 101:1026–1029
Seifert V, Stolke D, Kaever V, Dietz H (1987) Arachidonic acid metabolism following aneurysm rupture. Surg Neurol 27:243–252
Watanabe T, Asano T, Shimizu T, Seyama Y, Takakura K (1988) Participation of lipooxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem 50:1145–1150
Ohta S, Nishihara J, Oka Y, Todo H, Kumon Y, Sakaki S (1995) Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid haemorrhage. Acta Neurochir (Wien) 137:217–225
Zimpfer U, Hofmann C, Dichmann S, Schopf E, Norgauer J (1998) Synthesis, biological effects and pathophysiological implications of the novel arachidonic acid metabolite 5-oxo-eicosatetranoic acid (Review). Int J Mol Med 2:149–153
Pyne GJ, Cadoux-Hudson TAD, Clark JF (2003) Platelets play an essential role in the aetiology of cerebral vasospasm after subarachnoid haemorrhage. Med Hypotheses 60:525–530
Vieweg U, Schramm J, Urbach H (1999) Platelet derived growth factor (PGDF-AB)-like immune reactivity in serum and in cerebral spinal fluid following experimental subarachnoid haemorrhage in dogs. Acta Neurochir 141:861–866
Turner CP, Bergeron M, Matz P, Zegna A, Noble LJ, Panter SS, Sharp FR (1998) Heme oxygenase-1 (HO-1) is induced in glia throughout the brain by subarachnoid hemoglobin. J Cereb Blood Flow Metab 18:257–273
Tenhunen R, Ross ME, Marver HS, Schmid R (1970) Reduced nicotinamide-adenine dinucleotide phosphatse dependent biliverdin reductase: partial purification and characterization. Biochemistry 9:298–303
Wurster W, Pyne-Geithman GJ, Peat I, Clark JF (2007) Bilirubin oxidation products (BOXEs): synthesis, stability and chemical characteristics. Acta Neurochir Suppl 104:43–50
Loftspring M, Wurster WL, Pyne-Geithman GJ, Clark JF (2006) Molecular oxygen is required for oxidation of bilirubin in vitro. Society for Neuroscience (SfN). J. Neurosci, Atlanta
Wurster WL, Loftspring M, Pyne-Geithman GJ, Clark JF (2008) Bilirubin oxidation products (BOXes) are produced by biochemical oxidation involving free peroxynitrite. FASEB J 22:758.16
Wurster WL, Loftspring M, Pyne-Geithman GJ, Peat IR, Clark JF (2007) Bilirubin oxidation products (BOXes) are produced by biochemical oxidation involving free hemoglobin. Society for Neuroscience (SfN). J. Neurosci, San Diego
Wurster WL, Loftspring M, Pyne-Geithman GJ, Peat IR, Clark JF (2008) Bilirubin oxidation products (BOXes) are produced by biochemical oxidation involving xanthine oxidase. Society for Neuroscience (SfN). J. Neurosci, Washington, DC
Loftspring M, Wurster W, Pyne-Geithman GJ, Clark JF (2007) An in vitro model of aneurysmal subarachnoid hemorrhage: oxidation of unconjugated bilirubin by cytochrome oxidase. J Neurochem 102:1990–1995
Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ (1997) Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke 28:2031–2037
Pyne-Geithman G, Caudell D, Prakash P, Clark J (2009) Glutathione peroxidase and subarachnoid hemorrhage: implications for the role of oxidative stress in cerebral vasospasm. Neurol Res 31:195–199
Katayama T, Watanabe M, Tanaka H, Hino M, Miyakawa T, Ohki T, Ye L-H, Xie C, Yoshiyama S, Nakamura A, Ishikawa R, Tanokura M, Oiwa K, Kohama K (2010) Stimulatory effects of arachidonic acid on myosin ATPase activity and contraction of smooth muscle via myosin motor domain. Am J Physiol 298:H505–H514
Ratz PH, Miner AS, Barbour SE (2009) Calcium-independent phospholipase A2 participates in KCl-induced calcium sensitization of vascular smooth muscle. Cell Calcium 46:65–72
Hou S, Xu R, Clark JF, Wurster WL, Heinemann SH, Hoshi T (2011) Bilirubin oxidation end products directly alter K+ channels important in the regulation of vascular tone. J Cereb Blood Flow Metab 31:102–112
Faraci FM (1990) Role of nitric oxide in regulation of basilar artery tone in vivo. Am J Physiol 28:H1216–H1221
Harrison DG, WIdder J, Grumbach IM, Chen W, Weber M, Searles C (2006) Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 259:351–363
Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH (1996) Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648–654
Pluta RM, Thompson BG, Afshar JK, Boock RJ, Iuliano B, Oldfield EH (2001) Nitric oxide and vasospasm. Acta Neurochir Suppl 77:67–72
Gladwin MT, Lancaster MR Jr, Freeman BA, Schecter AN (2003) Nitric oxide reactions with hemoglobin: a view through the SNO-storm. Nat Med 9:496–500
Edwards DH, Byrne JV, Griffith TM (1992) The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 76:830–837
Sehba FA, Bederson JB (2006) Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 28:381–398
Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142
Dostmann W, Tegge W, Frank R, Nickl C, Taylor M, Brayden J (2002) Exploring the mechanisms of vascular smooth muscle tone with highly specific, membrane-permeable inhibitors of cyclic GMP-dependent protein kinase I alpha. Pharmacol Ther 93:203
Tuteja N, Chandra M, Tuteja R, Misra MK (2004) Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology. J Biomed Biotechnol 2004:227–237
Kitazawa T, Semba S, Huh YH, Kitazawa K, Eto M (2009) Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1. J Physiol 587:3587–3603
Laher I, Bevan JA (1987) Protein kinase C activation selectively augments a stretch induced, calcium dependent tone in vascular smooth muscle. J Pharmacol Exp Ther 242:566–572
Erdodi F, Rokolya A, Barany M, Barany K (1988) Phosphorylation of the 20,000-Da myosin light chain isoforms of arterial smooth muscle by myosin light chain kinase and protein kinase C. J Biochem Biophys 306:583–591
Haller H, Smallwood JI (1990) Protein kinase C translocation in intact vascular smooth muscle strips. Biochem J 270:375–381
Ruegg JC (2000) Smooth muscle; PKC-induced Ca2+ senstization by myosin phosphatase inhibition. J Physiol 520:3
Nishizawa S, Yamamoto S, Uemura K (1996) Interrelation between protein kinase C and nitric oxide in the development of vasospasm after subarachnoid hemorrhage. Neurol Res 18:89–95
Nishizawa S, Obara K, Nakayama K, Koide M, Yokoyama T, Yokota N, Ohta S (2000) Protein kinase Cδ and α are involved in the development of vasospasm after subarachnoid hemorrhage. Eur J Pharmacol 398:113–119
Barany M, Barany K (1996) Protein phosphorylation during contraction and relaxation. In: Barany M (ed) Biochemistry of smooth muscle contraction, vol 1. Academic, San Diego, pp 321–339
Sellers JR (1999) Unphosphorylated crossbridges and latch: smooth muscle regulation revisited. J Muscle Res Cell Motil 20:347–349
Murphy RA, Rembold CM, Hai C-M (1990) Contraction in smooth muscle. What is latch? Front Smooth Musc Res 327:39–50
Varsos V, Liszczak TM, Hee Lan D, Kistler JP, Vielma J, McL Black P, Heros RC, Zervas NT (1983) Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine or papaverine in a “two-hemorrhage” canine model. J Neurosurg 58:11–17
Pyne GJ, Cadoux-Hudson TAD, Clark JF (1998) Force-function relations in vascular smooth muscle during cerebral vasospasm. Biophys J 74:A256
Bolz S-SM, Vogel L, Sollinger D, Derwand RM, de Wit CM, Loirand GP, Pohl UMP (2003) Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributed to activation of the myosin light chain phosphatase and antagonized by the rhoa/rho kinase pathway. Circulation 107:3081–3087
Pyne G, Cadoux-Hudson T, Clark J (2000) The presence of an extractable substance in the CSF of humans with cerebral vasospasm after subarachnoid haemorrhage that correlates with phosphatase inhibition. Biochim Biophys Acta 1474:283–290
Butler TM, Narayan SR, Mooers SU, Siegman MJ (1994) Rapid turnover of myosin light chain phosphate during cross bridge cycling. Am J Physiol 267:C1160–C1166
Butler WE, Peterson JW, Zervas NT, Morgan KG (1996) Intracellular calcium, myosin light chain phosphorylation and contractile force in experimental cerebral vasospasm. Neurosurgery 38:781–788
Sato M, Tani E, Fujikawa H, Kaibuchi K (2000) Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm [see comments]. Circ Res 87:195–200
Feng J, Ito M, Ichikawa K, Isaki N, Nishikawa M, Hartshorne DJ, Nakano T (1999) Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274:37385–37390
Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T (2000) Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475:197–200
Nobe K, Paul RJ (2001) Distinct pathways of Ca2+ sensitization in porcine coronary artery. Effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca2+. Circ Res 88:1283–1290
Somlyo AP, Somlyo AV (2000) Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522:177–185
Pyne-Geithman GJ, Nair SG, Clark JF (2009) Rho-mediated stress fiber formation in smooth muscle esposed to bilirubin oxidation products: a mechanism for cerebral vasospasm. In: Tenth international conference on cerebral vasospasm, Thieme Chongqing, 2009
Brandt D, Gimona M, Hillman M, Haller H, Mischak H (2002) Protein kinase C induced actin reorganization via a Src- and Rho-dependent pathway. J Biol Chem 277:20903–20910
Ridley AJ, Hall A (1992) The small GTP-binding protein rho regulated the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389–399
Conflicts of Interest Statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Pyne-Geithman, G.J., Nair, S.G., Stamper, D.N.C., Clark, J.F. (2013). Role of Bilirubin Oxidation Products in the Pathophysiology of DIND Following SAH. In: Zuccarello, M., Clark, J., Pyne-Geithman, G., Andaluz, N., Hartings, J., Adeoye, O. (eds) Cerebral Vasospasm: Neurovascular Events After Subarachnoid Hemorrhage. Acta Neurochirurgica Supplement, vol 115. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1192-5_47
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1192-5_47
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1191-8
Online ISBN: 978-3-7091-1192-5
eBook Packages: MedicineMedicine (R0)